Cell And Gene Articles, App Notes, Case Studies, & White Papers
-
Studying The Spatial Architecture Of Glioblastoma
3/24/2025
Explore how intra-tumor heterogeneity (ITH) impacts cancer progression and therapy resistance with advanced imaging platforms and custom antibody panels to reveal the spatial architecture of glioblastoma (GBM).
-
Demonstration Of Scalability For A Novel Fixed Bed Reactor Platform
4/28/2025
Designed to enable efficient scalability, a new FBR platform allows operators to use one technology, with a standardized workflow, for their process development, scale-up, and manufacturing processes.
-
Quantification Of Total mRNA Content In LNP Complexes
11/21/2025
Learn how rapid, non-destructive techniques for mRNA quantification in LNPs can improve dosing accuracy, reduce variability, and accelerate decision-making for efficient scale-up and commercialization.
-
Expansion Of Cord Blood-Derived CD34+ Cells In A Hollow-Fiber Bioreactor With 10% Standard Cytokine Concentration
8/20/2024
CD34+ cells isolated from cord blood were expanded in a hollow-fiber bioreactor using a novel cytokine cocktail at one-tenth the standard concentration using a MSC-free coating strategy.
-
Accelerating Clinical Data Review With Traceable Workflows
12/3/2025
Clinical data review needs centralized access and traceable workflows. Leveraging AI-automation and real-time collaboration drives faster, better-informed decisions and reduced compliance risk.
-
Enhance DMC Services By Harnessing Biostatistics Expertise
8/7/2024
Discover how expert biostatistics and project management ensured data integrity and efficient DMC operations in a complex clinical trial for hematologic cancer cell therapies.
-
A Duplex Assay For Quantification And Qualification Of AAV
5/13/2025
Adeno-associated virus is a key gene therapy vector. Explore how digital PCR offers precise, standard-free quantification with improved consistency and inhibitor tolerance over traditional qPCR methods.
-
Optimizing Safety Measures For rAAV Therapies
10/11/2024
Explore common process-related impurities found in recombinant Adeno-Associated Virus (rAAV) vectors and the analytical testing methods used for these residuals.
-
Controlling mAb Aggregates In Chromatography Process Development
5/22/2026
Antibody aggregation remains a critical downstream challenge, particularly for complex modalities. Explore why aggregates form, why they matter, and how chromatographic strategies can help reduce risk.
-
Automating High-Throughput Screens Using Patient-Derived Organoids
3/17/2025
Many oncology drugs fail in later development stages due to inadequate predictive models. Explore how 3D cell models, like patient-derived organoids, offer a promising solution in the drug development process.